Golden Gate to Glycemic Control in T2D:

This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

This activity is supported by an educational grant from Lilly

Despite an expanding treatment landscape, many patients with type 2 diabetes (T2D) continue to experience suboptimal glycemic control, underscoring the need for improved insulin-based management strategies. Emerging once-weekly basal insulin formulations may address key limitations of once-daily analogues by simplifying regimens and improving Medic*tion adherence. Primary care practitioners (PCPs), who are often responsible for managing T2D, play a critical role in initiating, titrating, and adjusting insulin therapy alongside other antidiabetic agents. However, practical education on evolving insulin formulations and their real-world implementation remains limited in primary care training. This case-based educational initiative aims to address these gaps by preparing PCPs for the potential role of once-weekly basal insulin formulations while reinforcing core principles of insulin management in T2D. Delivered through an interactive game -show format, learners will compete in team-based treatment decision challenges supported by expert faculty discussion and evidence-based guidance.

Target Audience

This initiative is intended for primary care, family medicine, and internal medicine physicians; nurse practitioners; physician assistants; and other general practice providers.

Learning Objectives

After participating in this initiative, learners will be able to:

1. Assess the efficacy and safety of emerging once-weekly basal insulin therapies in T2D, considering insulin-naive and insulin-experienced patients

2. Develop strategies that support guideline-based early identification of individuals with T2D who would benefit from basal insulin therapy

3. Identify contributors to insulin therapeutic inertia and nonadherence that may be addressed with once-weekly basal formulas

4. Review education and communication strategies and resources that address patients’ educational needs surrounding growing treatments for T2D

Credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.

Criteria for Success

Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at [email protected].

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Catalyst Medical Education, LLC